Hamilelikte imidazole kullanmaktan kaçınmalı mıyım? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

imidazole hamilelikte güvenli mi?

Imidazole (CAS 288-32-4) is listed by ECHA with a harmonised classification for developmental toxicity (Category 1B, H360D), which by your scoring rules is H360-level evidence -> h=3. The mechanistic basis for the classification is not well‐characterised in publicly available dossiers, so mechanism is scored as theoretical/uncertain (m=1). Dermal/topical cosmetic exposure would likely give low but measurable systemic exposure for an adult (e=1) unless formulation/route increases uptake; this is supported by ECHA/EU classification and multiple safety data sheets listing H360D.

imidazole emzirirken güvenli mi?

Because imidazole has a harmonised developmental/teratogenic classification (H360D, Category 1B) the hazard for lactation/breastfeeding is elevated and scored h=3 per your rule for H360-level evidence. No specific human milk transfer or breastfeeding studies were identified in the sources consulted, so mechanistic evidence is limited (m=1). Maternal topical use would most likely give low but measurable systemic exposure (e=1) in adults; therefore potential transfer in milk cannot be excluded.

imidazole bebek cildi için güvenli mi?

Hazard remains H360-level (h=3) because of ECHA harmonised developmental classification. Mechanistic data are limited (m=1). For baby skin (0–3 yr) exposure scoring increases by +1 compared with adults when the adult exposure is measurable: adult e=1 -> infant e=2 because infant skin has higher surface-area-to-weight and an immature barrier, increasing potential absorption.

VeriMom imidazole nasıl puanlıyor?

VeriMom imidazole'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.

Hamilelikte imidazole yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.